Farrell Michael J. 4
4 · RESMED INC · Filed Nov 24, 2025
Insider Transaction Report
Form 4
RESMED INCRMD
Farrell Michael J.
DirectorChairman and CEO
Transactions
- Tax Payment
ResMed Common Stock
2025-11-20−7,297→ 466,223 total - Award
ResMed Common Stock
2025-11-20+13,551→ 473,520 total
Holdings
- 2,090(indirect: By Trust)
ResMed Common Stock
Footnotes (2)
- [F1]Represents performance-based restricted stock units granted on November 16, 2022. The shares were earned on November 20, 2025, when the compensation and leadership development committee certified that the performance metrics were met.
- [F2]Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted on November 16, 2022.